![(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (S)-propane-1,2-diol (…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F319814-1s-15-anhydro-1-c-4-chloro-3-4-ethoxyphenyl-methyl-phenyl-d-glucitol-s-propane-12-diol-1-1-monohydrate.webp&w=3840&q=75)
CAS 960404-48-2
:(1S)-1,5-Anidro-1-C-[4-cloro-3-[(4-etoxifenil)metil]fenil]-D-glucitol (S)-propano-1,2-diol (1:1) monohidrato
Fórmula:C21H25ClO6·C3H8O2·H2O
InChI:InChI=1S/C21H25ClO6.C3H8O2.H2O/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21;1-3(5)2-4;/h3-8,10,17-21,23-26H,2,9,11H2,1H3;3-5H,2H2,1H3;1H2/t17-,18-,19+,20-,21+;3-;/m10./s1
Chave InChI:InChIKey=GOADIQFWSVMMRJ-UPGAGZFNSA-N
SMILES:O[C@H]1[C@@H](O[C@H](CO)[C@@H](O)[C@@H]1O)C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2.[C@@H](CO)(C)O.O
Sinónimos:- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-<span class="text-smallcaps">D</span>-glucitol (S)-propane-1,2-diol (1:1) monohydrate
- <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol (1:1), monohydrate
- <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)
- Dapagliflozin (S)-propylene glycol hydrate
- Dapagliflozin Propylene Glycolate Hydrate
- Edistride
- Farxiga
- Forxiga
- D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol (1:1), monohydrate
- D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)
- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (S)-propane-1,2-diol (1:1) monohydrate
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 14 produtos.
Dapagliflozin Propanediol
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C21H25ClO6·C3H8O2·H2OCor e Forma:White Off-White PowderPeso molecular:502.19696Dapagliflozin ((2S)-1,2-propanediol, hydrate)
CAS:Dapagliflozin ((2S)-1,2-propanediol, hydrate)Fórmula:C24H35ClO9Pureza:≥98%Peso molecular:502.98D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)
CAS:Fórmula:C24H35ClO9Pureza:99%Cor e Forma:SolidPeso molecular:502.9823Ref: IN-DA00IMNP
1kgA consultar5kgA consultar100mg26,00€1g27,00€250mg30,00€5g40,00€25g84,00€100g208,00€500g688,00€Dapagliflozin Propanediol Hydrate
CAS:Dapagliflozin Propanediol HydrateFórmula:C24H35ClO9Pureza:99%Peso molecular:502.98Dapagliflozin ((2S)-1,2-propanediol, hydrate)
CAS:(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (S)-propane-1,2-diol hydrateFórmula:C24H35ClO9Pureza:99%Peso molecular:502.98Dapagliflozin propanediol monohydrate
CAS:Fórmula:C21H25ClO6·C3H8O2·H2OPureza:≥ 98.0%Cor e Forma:White to yellow or beige powder or solidPeso molecular:502.98Dapagliflozin (2S)-1,2-Propanediol Monohydrate
CAS:Fórmula:C21H25ClO6·C3H8O2·H2OCor e Forma:NeatPeso molecular:502.98Dapagliflozin ((2S)-1,2-propanediol, hydrate)
CAS:Dapagliflozin ((2S)-1,2-propanediol, hydrate) (BMS-512148 (2S)-1,2-propanediol, hydrate) is a selective, orally active inhibitor of the renal sodium-glucose co-Fórmula:C24H35ClO9Pureza:99.88% - 99.94%Cor e Forma:SolidPeso molecular:502.98Dapagliflozin Propanediol Monohydrate
CAS:Fórmula:C21H25ClO6C3H8O2H2OPeso molecular:408.88 : 76.09 : 18.0(2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL COMPOUND WITH (S)-PROPANE-1,2-DIOL (1:1) HYDRATE
CAS:Pureza:95%Peso molecular:502.989990234375Dapagliflozin Propanediol Hydrate
CAS:Fórmula:C21H25ClO6·C3H8O2·H2OCor e Forma:NeatPeso molecular:502.98Dapagliflozin propanediol monohydrate - Bio-X ™
CAS:Dapagliflozin is a sodium-glucose cotransporter subtype 2 (SGLT2) inhibitor that can be used in the treatment of diabetes mellitus type 2. It inhibits glucose reabsorption in the proximal tubule of the nephron and results in glycosuria, which helps to improve glycaemic control. Also, Dapagliflozin is used to lower the risk of sustained eGFR decline, end-stage renal disease, cardiovascular death, and hospitalization for heart failure in patients with chronic kidney disease who are at risk of progression.Fórmula:C21H25ClO6•C3H8O2•H2OPureza:Min. 95%Cor e Forma:PowderPeso molecular:502.98 g/molDapagliflozin propanediol monohydrate
CAS:Dapagliflozin is an oral antidiabetic drug that acts by inhibiting the SGLT2 enzyme. The SGLT2 enzyme is responsible for reabsorbing glucose from the kidney, so by inhibiting this enzyme, glucose will be excreted in the urine and blood glucose levels will decrease. Dapagliflozin also has a low bioavailability in vivo, which can be improved by administration with food. This drug has been shown to have a longer elimination half-life than canagliflozin and empagliflozin. Dapagliflozin has been shown to have a higher potency than metformin hydrochloride in vitro.Fórmula:C24H35ClO9Pureza:(Hplc) Min. 99.0%Cor e Forma:PowderPeso molecular:502.98 g/mol
![D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA00IMNP.jpg&w=3840&q=75)
